World

Sartorius and MAbSilico Unite AI and Cell Line Development to Accelerate Biologics Discovery

Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line development  The integrate...

 October 02, 2026 | News

Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing

Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...

 October 02, 2026 | News

Suvoda Expands Unified Clinical Trial Platform With AI-Powered Capabilities

- Suvoda, a global clinical trial technology company,  announced a new release of important advancements since unifying the market-leading Suvoda...

 October 02, 2026 | News

Health In Tech Launches AI-Powered HitRix Platform for Large-Group Health Insurance

AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby ...

 October 02, 2026 | News

CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis  ...

 October 01, 2026 | News

Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment throug...

 October 01, 2026 | Analysis

Lundbeck Relocates US Headquarters to Greater Boston, Establishes Global Innovation Hub

The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent ...

 September 28, 2026 | News

FDA Approves Mirum and Incyte’s Atebrioz for Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY)  announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz...

 September 28, 2026 | News

CooperVision Opens Global Innovation Hub in UK, Unveils Six Contact Lens Advancements

 CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced si...

 September 25, 2026 | News

Earendil Labs, Genentech Ink $1.5B+ Deal to Develop AI-Driven Bispecific Antibodies

Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member o...

 September 25, 2026 | News

Tech Mahindra, Verato Partner to Strengthen Data Foundations for AI-Driven Healthcare

The partnership gives U.S. health systems, payers, pharma, and device makers a trusted way to match patient, provider, and member records as they modernize...

 September 25, 2026 | News

Oracle Unveils AI-Powered Oncology EHR to Transform Cancer Care

Oracle Health and Life Sciences Summit – Oracle today announced its Oracle Health Oncology EHR. Building on the capabilities of Oracle's modern,...

 September 25, 2026 | News

Thermo Fisher Launches CHO-K1 Media Panel to Boost Biologics Production

Thermo Fisher Scientific, the world leader in serving science, announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed me...

 September 24, 2026 | News

Daiichi Sankyo, AstraZeneca’s Enhertu Wins EU Panel Backing for Early Breast Cancer

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% vers...

 September 21, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close